Post by Ajinomoto Bio-Pharma Services

19,220 followers

Explore where innovation meets impact. At our Kawasaki R&D facility, CORYNEX® is enabling the next generation of biologics. From long-chain peptides to antibody mimetics and VHHs, our microbial expression platform enables efficient, scalable production with high purity and simplified downstream processing. Heading to CPHI Japan? Connect with our team to learn more: https://bit.ly/4tj1ua3

Post content

Video Content